|Podcasts|September 17, 2020
Episode 65: Creating a Path for Innovation
Author(s)Elaine Quilici
George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to market in Scotland.
Advertisement
George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to market in Scotland.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines
3
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
4
Why CMS Is Tightening ASP Reporting and What Manufacturers Must Get Right
5